Survival outcome and neurotoxicity in patients of high-grade gliomas treated with conformal radiation and temozolamide

Journal of Cancer Research and Therapeutics

Volumn 8, Issue 1, 2012, Pages 50-56

  Anand, Anil Kumar ^a   Chaudhory, Amal Roy ^a   Aggarwal, Har Narain ^b   Sachdeva, Pushpender Kumar ^c   Negi, Pritam Singh ^a   Sinha, Sujit Sinha ^a   Babu, Ananda Giri ^a   Jena, Amarnath ^c   Rao, Avinash ^c   Chaudhury, Partha S ^c  

^a Max Hospital   (India)

^b Department of Orthopaedics   (India)

^c RAJIV GANDHI CANCER INSTITUTE AND RESEARCH CENTRE   (India)

Author keywords

High grade gliomas; neurotoxicity; survival

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED RADIOTHERAPY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLIOMA; HUMAN; IMAGE ANALYSIS; INTENSITY MODULATED RADIATION THERAPY; MALE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR BIOPSY;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84860460751     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.95174     Document Type: Article

References (25)

1. Stupp R, Mason WP, Van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomittant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96. (Pubitemid 40349501)
2. Schlegel U, Pels H, Oehring R, Blumcke I. Neurologic sequelae of treatment of primary CNS lymphomas. J Neurooncol 1999;43:277-86. (Pubitemid 29488386)
3. Keime-Guibert F, Napolitano M, Delatttre JY. Neurological complication of radiotherapy and chemotherapy. J Neurol 1998;245:695-708.
4. Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, et al. Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy and Chemotherapy induced Necrosis of the Brain after Treatment. Radiology 2000;217:377-84.
5. MacDonald SM, Ahmad S, Kachris S, Vogds BJ, DeRouen M, Gittleman AE, et al. Intensity modulated radiation therapy versus three dimensional conformal radiation therapy for the treatment of high grade glioma: A dosimetric comparison. J Appl Clin Med Phys 2007;8:47-60.
6. Siker ML, Donahue BR, Vogelbaum MA, Tome WA, Gilbert MR, Mehta MP, et al. Primary Intracranial Neoplasms. Principles and Practice of Radiation Oncology. In: Halperrin EC, Perez CA, Brady LW, editors. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2008. p. 717-50.
7. Narayana A, Yamada J, Berry S, Shah P, Hunt M, Gutin PH, et al. Intensity modulated radiotherapy in High Grade Gliomas. Clinical and Dosimetric Results. Int J Radiat Oncol Biol Phys 2006;64:892-7. (Pubitemid 43183590)
8. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0. Available from: http://www.eortc.be/services/doc/ ctc/ctcaev3.pdf. [Last accessed on 2006 Aug 9].
9. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
10. Laack NN, Brown PD, Ivnik RJ, Furth AF, Ballman KV, Hammack JE, et al. Cognitive function after radiotherapy for supratentorial low grade glioma: A North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys 2005;63:1175-83. (Pubitemid 41505297)
11. Postma TJ, Klein M, Verstappen CC, Bromberg JE, Swennen M, Langendijk JA, et al. Radiotherapy induced cerebral abnormalities in patients with low grade glioma. Neurology 2002;59:121-3. (Pubitemid 34742806)
12. Floyd NS, Woo SY, Teh BS, Prado C, Mai WY, Trask T, et al. Hypo fractionated intensity modulated radiotherapy for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2004;58:721-6. (Pubitemid 38221127)
13. Stupp R, Hegi ME, Mason PW, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effect of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5 -year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459-66.
14. Herrlinger U, Rieger J, Koch D, Loeser S, Blaschke B, Kortmann RD, et al. Phase II trial of Lomustine plus Temozolomide chemotherapy in addition to radiotherapy in newly diagnosed Glioblastoma. UKT -03. J Clin Oncol 2006;24:4412-7. (Pubitemid 46630979)
15. Constine LS, Konski A, Ekholm S, McDonald S, Rubin P. Adverse effect of brain irradiation correlated with MR and CT imaging. Int J Radiat Oncol Biol Phys 1988;15:319-30.
16. Valk PE, Dillon WP. Diagnostic imaging of central nervous system radiation injury. In: Gutin P, Leibel S, Sheline G, editors. Radiation injury to the nervous system. Chapt. 12. New York: Raven Press; 1991. p. 211-37.
17. Hochberg FH, Slotnick BB. Neuropsychologic impairment in astrocytoma survivors. Neurology 1980;30:172-7. (Pubitemid 10133437)
18. Packer RJ, Zimmerman RS, Bilaniuk LT. Magnetic resonance imaging in the evaluation of treatment related central nervous system damage. Cancer 1986;58:635-40. (Pubitemid 16072064)
19. Burger P, Boyko OB. Radiation injury to the nervous system. The pathology of central nervous system radiation injury. In: Gutin, P, Leibel S, Sheline G, editors. New York: Raven Press; 1991. p. 191-208.
20. Tsuruda JS, Kortman KE, Bradley WG, Wheeler DC, Van Dalsem W, Bradley TP. Radiation effects on cerebral white matter: MR evaluation. AJR Am J Roentgenol 1987;149:165-71. (Pubitemid 17095022)
21. Scott JN, Rewcastle NB, Brasher PM, Fulton D, Hagen NA, MacKinnon JA, et al. Long term Glioblastoma multiforme survivors: A population based study. Can J Neurol Sci 1998;25:197-201.
22. Swennen MH, Bromberg JE, Witkamp TD, Terhaard CH, Postma TJ, Taphoorn MJ. Delayed radiation toxicity after focal or whole brain radiotherapy for low grade glioma. J Neurooncol 2004;66:333-9. (Pubitemid 38258348)
23. Johannesen TB, Lein HH, Hole KH, Lote K. Radiological and clinical assessment of long term brain tumor survivors after radiotherapy. Radiother Oncol 2003;69:169-76. (Pubitemid 37485876)
24. Cancer Therapy Evaluation Program, Common Toxicity Criteria, Version 2.0, DCTD, NCI, NIH, DHHS, March 1998. Available from: http://www.ctep.cancer.gov, [Last accessed on 1999 Apr 30].
25. Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, et al. Survival and failure patterns of high grade gliomas after three dimensional conformal radiotherapy. J Clin Oncol 2002;20:1635-42. (Pubitemid 34260545)